文献速递安宁疗护

长期护理院医生计费与临终症状管理药物处方的关联:基于人群的回顾性队列研究

Physician Billing in Long-Term Care Homes and the Association With the Prescribing of End-of-Life Symptom Management Medications: A Population-Based Retrospective Cohort Study.
PubMed 文献 · J Am Med Dir Assoc · 2025-07-23

该研究基于加拿大安大略省626家公立长期护理院2017年1月1日至2020年3月17日期间所有逝者(54445例)及其最负责医生(1855名),评估医生在长期护理院的计费比例与逝者临终前2周内获得临终症状管理药物处方之间的关联。结果显示,三分之二(67.4%)逝者至少有一种临终药物处方,最常见为阿片类(65.4%);医生计费比例每增加10%,处方几率的调整比值比为1.01(95%CI 0.99-1.02),无显著关联。

要点

  • 长期护理院逝者中67.4%在临终前2周内获得至少一种临终症状管理药物处方。
  • 阿片类药物是最常见的临终症状管理药物,处方率达65.4%。
  • 医生在长期护理院的计费比例与临终药物处方几率无显著关联(aOR 1.01,95%CI 0.99-1.02)。

核心结论

  • 安大略省长期护理院临终症状管理药物处方率存在较大差异,但医生在长期护理院的计费比例与处方几率无关。

研究设计与样本

  • 回顾性队列研究,使用行政健康数据,纳入安大略省626家公立长期护理院2017年1月1日至2020年3月17日期间所有逝者(54445例)及匹配的最负责医生(1855名)。

主要发现

  • 医生在长期护理院的总计费比例中位数为9%(四分位距3%至23%)。
  • 67.4%(36682例)的逝者在临终前2周内至少有一种临终症状管理药物处方,其中阿片类处方率为65.4%。
  • 医生计费比例每增加10%,逝者获得临终药物处方的调整比值比为1.01(95%CI 0.99-1.02),无统计学显著差异。

临床怎么用

  • 医生在长期护理院的计费比例不宜作为判断其临终症状管理处方积极性的依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Medications are often needed to manage distressing end-of-life symptoms (eg, pain, agitation, dyspnea). We evaluated whether physician billing in long-term care (LTC) was associated with LTC residents' receipt of an end-of-life symptom management medication prescription. DESIGN: Retrospective cohort study using administrative health data. SETTING AND PARTICIPANTS: All LTC decedents in Ontario's 626 publicly funded LTC homes who died between January 1, 2017, and March 17, 2020, were matched to a physician most responsible for their care (MRP) in LTC. METHODS: We measured the proportion of an MRP's billings that occurred in LTC. The prescribing of 1+ end-of-life symptom management medications was captured in LTC residents' last 2 weeks of life using prescription claims data. RESULTS: The study included 54,445 LTC decedents and 1855 MRPs. MRPs had a median of 9% of their total billings in LTC (interquartile range 3% to 23%). Two-thirds of LTC decedents (36,682, 67.4%) had at least one end-of-life medication prescription, the most common of which was opioids (prescribed to 65.4% of decedents). There was no difference in the odds of a decedent having a prescription for an end-of-life medication based on their MRP's proportion of billings in LTC (adjusted odds ratio for a 10% increase in an MRPs' billings in LTC 1.01, 95% CI, 0.99-1.02). CONCLUSIONS AND IMPLICATIONS: Across Ontario's LTC homes, there are large variations in prescribing rates for end-of-life symptom management medications; however, a physician's proportion of billings in LTC was not associated with a greater likelihood of prescribing.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Roberts RL, Clarke AE, Howard M, et al. Physician Billing in Long-Term Care Homes and the Association With the Prescribing of End-of-Life Symptom Management Medications: A Population-Based Retrospective Cohort Study. J Am Med Dir Assoc. 2025. PMID: 40651501. doi:10.1016/j.jamda.2025.105766

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。